<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133834/" ref="ordinalpos=3286&amp;ncbi_uid=3118379&amp;link_uid=PMC3133834" image-link="/pmc/articles/PMC3133834/figure/f3/" class="imagepopup">FIG. 3. From: Aerosol Therapy for the Treatment of Osteosarcoma Lung Metastases: Targeting the Fas/FasL <span class="highlight" style="background-color:">Pathway</span> and Rationale for the Use of Gemcitabine. </a></div><br /><div class="p4l_captionBody">Blocking the Fas signaling pathway allows Fas+ cells to induce lung metastases following i.v. injection. Fas+ K7 cells were transfected with FDN, Fas-associated death domain dominant negative or a control (neo) vector and injected into mice. Mice were euthanized 4 weeks later, and lung metastases were quantified.</div></div>